Viral Vaccines

"Viral Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.

Descriptor ID	D014765
MeSH Number(s)	D20.215.894.899
Concept/Terms	Viral Vaccines Viral Vaccines Vaccines, Viral

Below are MeSH descriptors whose meaning is more general than "Viral Vaccines".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Viral Vaccines [D20.215.894.899]

Below are MeSH descriptors whose meaning is related to "Viral Vaccines".

Below are MeSH descriptors whose meaning is more specific than "Viral Vaccines".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Viral Vaccines" by people in this website by year, and whether "Viral Vaccines" was a major or minor topic of these publications.

Bar chart showing 35 publications over 20 distinct years, with a maximum of 4 publications in 2006 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2002	0	1	1
2003	1	0	1
2004	1	2	3
2006	3	1	4
2007	2	0	2
2008	1	1	2
2012	3	0	3
2013	1	0	1
2014	1	0	1
2015	1	0	1
2017	1	0	1
2018	1	0	1
2019	2	0	2
2020	1	0	1
2021	2	0	2
2022	4	0	4
2023	2	0	2
2024	0	1	1
2025	1	0	1

Below are the most recent publications written about "Viral Vaccines" by people in Profiles.

Mayerlen LI, Wong TAS, To A, Smith O, Chuang E, Donini O, Lehrer AT. Thermostable bivalent & trivalent filovirus vaccines from insect cells: potency demonstrated after 3?months and 2?years. Vaccine. 2025 Oct 03; 64:127684.

View in: PubMed
Hosen T, Huq S, Abdullah-Al-Shoeb M, Islam S, Azad MAK. An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines. J Infect Dev Ctries. 2024 Jul 29; 18(7):1090-1099.

View in: PubMed
To A, Wong TAS, Ball AH, Lieberman MM, Yalley-Ogunro J, Cabus M, Nezami S, Paz F, Elyard HA, Borisevich V, Agans KN, Deer DJ, Woolsey C, Cross RW, Geisbert TW, Donini O, Lehrer AT. Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine. 2024 01 25; 42(3):598-607.

View in: PubMed
Perkins-Oines S, Dias N, Krafsur G, Abdelsalam K, Perry G, Ensley D, Jones C, Chase CCL. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica. Vaccine. 2023 05 05; 41(19):3080-3091.

View in: PubMed
Bamouh Z, Hamdi J, Elkarhat Z, Fellahi S, Omari Tadlaoui K, Watts DM, Fassi Fihri O, Elharrak M. Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus. Vaccine. 2022 10 26; 40(45):6471-6480.

View in: PubMed
Watts DM, Westover JLB, Palermo PM, Bailey KW, Morrill JC, Bettinger GE, Monath TP, Smith DR, Peters CJ, Pittman PR, Orbegozo J, Gowen BB. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.

View in: PubMed
Preston KB, Wong TAS, Lieberman MM, To A, Lai CY, Granados A, Thomasson H, Misamore J, Yalley-Ogunro J, Cabus M, Andersen H, Donini O, Lehrer AT, Randolph TW. Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80-Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human Primates. J Pharm Sci. 2022 12; 111(12):3424-3434.

View in: PubMed
Tarabini RF, Rigo MM, Faustino Fonseca A, Rubin F, Bell? R, Kavraki LE, Ferreto TC, Amaral Antunes D, de Souza APD. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2. Front Immunol. 2021; 12:812176.

View in: PubMed
Preston KB, Wong TAS, To A, Tashiro TE, Lieberman MM, Granados A, Feliciano K, Harrison J, Yalley-Ogunro J, Elyard HA, Donini O, Lehrer AT, Randolph TW. Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant. Vaccine. 2021 09 15; 39(39):5650-5657.

View in: PubMed
Ricci G, Minsker K, Kapish A, Osborn J, Ha S, Davide J, Califano JP, Sehlin D, Rustandi RR, Dick LW, Vlasak J, Culp TD, Baudy A, Bell E, Mukherjee M. Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO. Sci Rep. 2021 04 01; 11(1):7432.

View in: PubMed

People

Explore

Similar Concepts

Top Journals